• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-200c通过靶向乳酸脱氢酶A抑制膀胱癌进展。

MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.

作者信息

Yuan Daozhang, Zheng Shunsheng, Wang Liyan, Li Jing, Yang Jianan, Wang Bin, Chen Xiong, Zhang Xiaobo

机构信息

Department of Urology, Cancer Center of Guangzhou Medical University, Guangzhou, People's Republic of China.

Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

出版信息

Oncotarget. 2017 Jun 28;8(40):67663-67669. doi: 10.18632/oncotarget.18801. eCollection 2017 Sep 15.

DOI:10.18632/oncotarget.18801
PMID:28978061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5620201/
Abstract

Lactate dehydrogenase A (LDHA) is overexpressed in various cancers. We investigated LDHA expression and function in bladder cancer. We demonstrate that LDHA is up-regulated in bladder cancer cells and promotes proliferation, invasion, and glycolysis. Additionally, we found that microRNA (miR)-200c directly targets LDHA in bladder cancer cells. Ectopic expression of miR-200c inhibited LDHA-induced glycolysis, cell proliferation, and invasion. Thus, targeting LDHA through miR-200c is a potential therapeutic strategy in bladder cancer.

摘要

乳酸脱氢酶A(LDHA)在多种癌症中过表达。我们研究了LDHA在膀胱癌中的表达及功能。我们证明,LDHA在膀胱癌细胞中上调,并促进细胞增殖、侵袭和糖酵解。此外,我们发现微小RNA(miR)-200c在膀胱癌细胞中直接靶向LDHA。miR-200c的异位表达抑制了LDHA诱导的糖酵解、细胞增殖和侵袭。因此,通过miR-200c靶向LDHA是膀胱癌的一种潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/70abee0223fa/oncotarget-08-67663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/e8958842f3ab/oncotarget-08-67663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/36cde5bb8158/oncotarget-08-67663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/d5e305be7b4f/oncotarget-08-67663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/70abee0223fa/oncotarget-08-67663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/e8958842f3ab/oncotarget-08-67663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/36cde5bb8158/oncotarget-08-67663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/d5e305be7b4f/oncotarget-08-67663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b10e/5620201/70abee0223fa/oncotarget-08-67663-g004.jpg

相似文献

1
MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.微小RNA-200c通过靶向乳酸脱氢酶A抑制膀胱癌进展。
Oncotarget. 2017 Jun 28;8(40):67663-67669. doi: 10.18632/oncotarget.18801. eCollection 2017 Sep 15.
2
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.受微小RNA负调控的乳酸脱氢酶A促进有氧糖酵解并在结直肠癌中升高。
Oncotarget. 2015 Aug 14;6(23):19456-68. doi: 10.18632/oncotarget.3318.
3
MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis.MiR-204-3p通过调节乳酸脱氢酶介导的糖酵解抑制膀胱癌细胞的增殖。
Front Oncol. 2019 Nov 29;9:1242. doi: 10.3389/fonc.2019.01242. eCollection 2019.
4
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.miR-34a-LDHA轴调节乳腺癌中的葡萄糖代谢和肿瘤生长。
Sci Rep. 2016 Feb 23;6:21735. doi: 10.1038/srep21735.
5
FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.FOXM1-LDHA信号通路促进胃癌的糖酵解表型及进展。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6756-63. eCollection 2015.
6
miR-200c inhibits breast cancer proliferation by targeting KRAS.微小RNA-200c通过靶向KRAS抑制乳腺癌增殖。
Oncotarget. 2015 Oct 27;6(33):34968-78. doi: 10.18632/oncotarget.5198.
7
Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis.Fbw7通过靶向LDHA/乳酸/miR-223轴的正反馈环抑制活化B细胞样弥漫性大B细胞淋巴瘤的进展。
Front Oncol. 2022 Mar 10;12:842356. doi: 10.3389/fonc.2022.842356. eCollection 2022.
8
Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells.吲哚 - 3 - 甲醇使p53稳定以诱导miR - 34a,miR - 34a靶向乳酸脱氢酶A(LDHA)以阻断肝癌细胞中的有氧糖酵解。
Pharmaceuticals (Basel). 2022 Oct 13;15(10):1257. doi: 10.3390/ph15101257.
9
miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.miR-26b 通过下调 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶-3 驱动的糖酵解抑制骨肉瘤细胞的增殖、迁移、侵袭和凋亡诱导。
Oncol Rep. 2015 Apr;33(4):1890-8. doi: 10.3892/or.2015.3797. Epub 2015 Feb 12.
10
Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.微小RNA-34a对乳酸脱氢酶A的抑制作用使结肠癌细胞对5-氟尿嘧啶重新敏感。
Mol Med Rep. 2015 Jan;11(1):577-82. doi: 10.3892/mmr.2014.2726. Epub 2014 Oct 21.

引用本文的文献

1
Two metabolic enzymes, LDH and FASN, serum levels in Bladder cancer patients.两种代谢酶,即乳酸脱氢酶(LDH)和脂肪酸合酶(FASN)在膀胱癌患者中的血清水平。
Caspian J Intern Med. 2024 Aug 30;15(4):636-643. doi: 10.22088/cjim.15.4.636. eCollection 2024 Fall.
2
Advancements in research on lactate dehydrogenase A in urinary system tumors.在泌尿系统肿瘤中乳酸脱氢酶 A 的研究进展。
BMC Urol. 2024 Aug 30;24(1):187. doi: 10.1186/s12894-024-01580-y.
3
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.

本文引用的文献

1
EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery.表皮生长因子受体靶向脂质体寡聚物用于抗肿瘤 siRNA 和 miRNA 的递药。
Nanotechnology. 2016 Nov 18;27(46):464001. doi: 10.1088/0957-4484/27/46/464001. Epub 2016 Oct 13.
2
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
3
Metabolic Consequences of LDHA inhibition by Epigallocatechin Gallate and Oxamate in MIA PaCa-2 Pancreatic Cancer Cells.表没食子儿茶素没食子酸酯和草氨酸对MIA PaCa-2胰腺癌细胞中乳酸脱氢酶A(LDHA)抑制的代谢后果
探索达芦那韦、利匹韦林和依曲韦林作为膀胱癌潜在治疗方法的疗效及协同作用
Biomedicines. 2024 Mar 14;12(3):647. doi: 10.3390/biomedicines12030647.
4
One-Pot Analytical Pipeline for Efficient and Sensitive Proteomic Analysis of Extracellular Vesicles.一种用于高效灵敏的细胞外囊泡蛋白质组学分析的一锅煮分析流程。
J Proteome Res. 2023 Oct 6;22(10):3301-3310. doi: 10.1021/acs.jproteome.3c00361. Epub 2023 Sep 13.
5
: Insights into hybrid E/M phenotype attitudes.对混合E/M表型态度的见解
Front Cell Dev Biol. 2022 Nov 18;10:1038841. doi: 10.3389/fcell.2022.1038841. eCollection 2022.
6
The role of miR-200 family in the regulation of hallmarks of cancer.miR-200家族在癌症特征调控中的作用。
Front Oncol. 2022 Sep 8;12:965231. doi: 10.3389/fonc.2022.965231. eCollection 2022.
7
MicroRNAs as Regulators of Cancer Cell Energy Metabolism.作为癌细胞能量代谢调节因子的微小RNA
J Pers Med. 2022 Aug 18;12(8):1329. doi: 10.3390/jpm12081329.
8
Bladder cancer cell lines adapt their aggressiveness profile to oxygen tension.膀胱癌细胞系会根据氧张力调整其侵袭性特征。
Oncol Lett. 2022 May 20;24(1):220. doi: 10.3892/ol.2022.13341. eCollection 2022 Jul.
9
Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.糖酵解/胆固醇生成基因表达的改变与膀胱癌预后和免疫细胞浸润有关。
BMC Cancer. 2022 Jan 3;22(1):2. doi: 10.1186/s12885-021-09064-0.
10
Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue.特发性肺纤维化肺组织游离植体中肺泡 II 型细胞的乳酸代谢功能障碍。
Respir Res. 2021 Oct 28;22(1):278. doi: 10.1186/s12931-021-01866-x.
Metabolomics. 2015 Feb;11(1):71-80. doi: 10.1007/s11306-014-0672-8.
4
Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.SIP1的表达与LDHA密切相关,且在胃癌中显示出显著较差的预后。
Tumour Biol. 2015 Sep;36(10):7521-30. doi: 10.1007/s13277-015-3470-7. Epub 2015 Apr 26.
5
Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.通过下一代测序分析前列腺癌中微小RNA的表达谱
Prostate. 2015 Apr 1;75(5):500-16. doi: 10.1002/pros.22936. Epub 2015 Jan 16.
6
The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.miR-200c/141的下调促进ZEB1/2的表达及胃癌进展。
Med Oncol. 2015 Jan;32(1):428. doi: 10.1007/s12032-014-0428-3. Epub 2014 Dec 12.
7
miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.微小RNA-200c通过下调BMI-1和E2F3抑制膀胱癌细胞的侵袭、迁移和增殖。
J Transl Med. 2014 Nov 4;12:305. doi: 10.1186/s12967-014-0305-z.
8
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.醛脱氢酶 1 鉴定出人肾透明细胞癌细胞系中具有癌症干细胞样特性的细胞。
PLoS One. 2013 Oct 8;8(10):e75463. doi: 10.1371/journal.pone.0075463. eCollection 2013.
9
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2013 年更新版。
Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
10
Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells.上皮间质转化,通过 COX-2/MMP2、9/Snail、ZEB1 和 miR-200c/ZEB1 通路,介磺菌胺在人膀胱癌细胞中的新靶点。
J Nutr Biochem. 2013 Jun;24(6):1062-9. doi: 10.1016/j.jnutbio.2012.08.004. Epub 2012 Nov 13.